Can Endometriosis Increase Your Risk for Miscarriage? An Evidence-Based Guide
Clinical Guidance & Evidence Review
Medically Reviewed by Andrea Vidali, MD
Founder & Director, Endometriosis Surgical Specialists International (ESSI)
Fellowship-Trained Reproductive Endocrinologist & Infertility Specialist (REI), Master Excision Surgeon
Key Takeaways
- Elevated Relative Risk: Large epidemiological studies indicate that endometriosis carries a statistically higher risk of spontaneous pregnancy loss, particularly in patients with concurrent subfertility.
- Uterine Receptivity Over Egg Quality: For decades, early loss was blamed solely on egg quality. Modern reproductive endocrinology shows the primary bottleneck is often the uterine environment—driven by progesterone resistance and impaired endometrial receptivity.
- Adenomyosis & Endometriosis Coexistence: Adenomyosis coexists in up to 60% of complex endometriosis cases, directly disrupting the uterine junctional zone, provoking hyper-contractility, and impairing early placental development.
- Integrated, Uterine-Sparing Surgical Clearance: Treating this pathology requires a unified operative approach: meticulous laparoscopic excision of all pelvic endometriosis paired with fertility-focused, uterine-sparing treatments for adenomyosis (such as targeted microwave or radiofrequency ablation) in a single surgical strategy.
- Systemic Immune Dysregulation: Ectopic pelvic inflammation, altered natural killer (NK) cell cytotoxicity, and autoantibodies disrupt maternal-fetal immunological tolerance, predisposing to implantation failure and micro-thrombosis.
Understanding the Baseline: Miscarriages in the General Population
Before examining how endometriosis influences pregnancy maintenance, it is essential to contextualize baseline pregnancy loss.
Early pregnancy loss is remarkably common across the general population:
- According to the March of Dimes and the American College of Obstetricians and Gynecologists (ACOG), approximately 10% to 15% of clinically recognized pregnancies end in miscarriage.
- Roughly 80% of miscarriages occur within the first trimester (before 13 weeks of gestation).
- Up to 50% of all conceptions terminate before a person even detects an elevated hCG level on a home pregnancy test.
- In the general population, approximately 50% to 70% of sporadic first-trimester losses are caused by random chromosomal aneuploidies in the embryo.
However, when pregnancy loss occurs in the presence of endometriosis, secondary biological drivers beyond random genetic errors frequently come into play.
What the Research Says About Endometriosis and Miscarriage
The association between endometriosis and elevated miscarriage risk has transitioned from clinical observation to robust epidemiological evidence:
- The Santulli Cohort Analysis: A landmark study evaluating hundreds of pregnancies demonstrated that individuals with surgically confirmed endometriosis had a 29% prior miscarriage rate, compared to 19% in unaffected controls.
- The Impact of Subfertility: In patients with both endometriosis and a documented history of subfertility, the miscarriage rate rose to 53%, compared to 30% in subfertile controls without endometriosis.
- Multicenter Systematic Reviews: Broad systematic reviews encompassing spontaneous and assisted reproduction cycles report an overall 60% to 80% increased odds of miscarriage in patients with active endometriosis compared to healthy peers.
- Subsequent Pregnancy Losses: Population registries indicate that when systemic pelvic inflammation remains unaddressed, the likelihood of recurrent loss can compound with each successive cycle.
“For years, patients were told that endometriosis only creates mechanical barriers to getting pregnant—blocked tubes or distorted ovaries. But as reproductive endocrinologists, we know that getting pregnant is only step one. Endometriosis and coexisting adenomyosis actively alter the hormonal and immunological terrain required to stay pregnant.”
— Dr. Andrea Vidali, MD (REI & Master Excision Surgeon)
The Three Mechanisms: Why Endometriosis Disrupts Early Pregnancy
When pregnancy loss occurs alongside endometriosis, three distinct, interconnected biological pathways drive the deficit:
1. The Uterine Environment & Implantation Deficits
For decades, standard fertility clinics assumed that failed early pregnancy was primarily an oocyte issue. However, 30 years of donor-egg trials—in which young, healthy donor eggs are transferred into recipients with endometriosis—demonstrate that implantation and clinical pregnancy rates remain lower even when embryo quality is held constant. The deficit is primarily uterine.
Progesterone Resistance: Progesterone converts the proliferative uterine lining into a quiet, secretional surface capable of sustaining an embryo (decidualization). In endometriosis, the endometrium exhibits severe progesterone receptor downregulation and signaling resistance, leaving the lining in an unreceptive, estrogen-dominant state during the implantation window.
Epigenetic Gene Silencing: Critical receptivity and adhesion genes—most notably HOXA10 and BCL-6—are abnormally methylated or silenced, prematurely closing or distorting the window of implantation.
Loss of Receptive Cell Subsets: Single-cell RNA sequencing demonstrates that specific populations of receptive stromal cells normally present in healthy endometrium are depleted or absent in individuals with endometriosis.
2. Reproductive Immunology & Loss of Maternal Tolerance
A developing embryo is semi-allogeneic, expressing paternal antigens foreign to the maternal host. A successful pregnancy requires the maternal immune system to dial down cytotoxic defense and establish active immunological tolerance. In endometriosis, systemic and local immune regulation is fundamentally altered.
Peritoneal Cytokine Storm: Active ectopic lesions flood the pelvic cavity with pro-inflammatory mediators—including interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-alpha (TNF-α)—creating a toxic microenvironment that triggers maternal immune overactivity.
Uterine Natural Killer (uNK) Cell Dysregulation: Aberrant uNK cell density and cytotoxic activity disrupt the delicate trophoblast invasion and early spiral artery remodeling required to establish healthy maternal-fetal circulation.
Autoantibody Activation & Micro-Thrombosis: Patients with endometriosis have a heightened prevalence of antiphospholipid and antinuclear autoantibodies. These promote micro-vascular inflammation and micro-clotting at the maternal-placental interface, predisposing to early placental detachment and pregnancy loss.
3. The Oocyte Microenvironment (Ovarian Endometriomas)
While the uterine lining and immune system represent the primary barriers, egg quality is not entirely immune—particularly in advanced disease.
Toxic Follicular Fluid: In patients with Stage 3 or Stage 4 disease involving large ovarian endometriomas (“chocolate cysts”), free iron accumulation and chronic oxidative stress permeate the surrounding ovarian cortex.
Mitochondrial Dysfunction: Reactive oxygen species (ROS) in the follicular fluid can impair oocyte spindle assembly and mitochondrial bioenergetics, leading to lower fertilization efficiency, compromised embryo division, and higher developmental arrest.
The Hidden Co-Factor: Adenomyosis & The Uterine Muscle
It is clinically incomplete to evaluate endometriosis without investigating adenomyosis—the invasion of endometrial glands directly into the muscular uterine wall (myometrium).
Adenomyosis coexists in an estimated 40% to 60% of patients with complex endometriosis:
- Junctional Zone Disruption: It thickens and distorts the junctional zone, disrupting the architectural base needed for deep endovascular trophoblast invasion.
- Myometrial Hyper-Contractility: Chronic inflammation in the uterine muscle causes rhythmic, dysregulated contractions that can mechanically displace fragile early embryos.
- Defective Placentation: Incomplete vascular remodeling of maternal spiral arteries increases the rates of first-trimester loss, second-trimester miscarriages, intrauterine growth restriction (IUGR), and preeclampsia.
“If a patient has had multiple euploid (chromosomally normal) embryo losses, looking for endometriosis in the pelvis while ignoring adenomyosis in the uterine wall is an incomplete evaluation. High-resolution 3D ultrasound or specialized pelvic MRI is essential to identify junctional zone disease and plan a targeted, uterine-sparing surgical approach before attempting another transfer.”
— Dr. Andrea Vidali, MD
Comparing Miscarriage Symptoms vs. Routine Endometriosis Flares
Patients with endometriosis frequently experience severe cyclical cramps and irregular spotting, making it difficult to differentiate routine disease symptoms from a threatened loss.
| Symptom Feature | Routine Endometriosis Flare | Acute Miscarriage Presentation |
|---|---|---|
| Bleeding Characteristics | Brown spotting, dark premenstrual discharge, or steady menstrual flow. | Sudden, bright red vaginal bleeding; soaking through a pad in under an hour; passing large clots or tissue. |
| Pain Profile | Chronic aching, stabbing pelvic pain, rectal/nerve radiating pain, or severe dysmenorrhea. | Progressive, rhythmic cramping in the lower abdomen or severe lumbar pressure that builds in intensity. |
| Timing | Cyclical (peaking around menses/ovulation) or chronic daily pelvic aching. | Occurs after a confirmed positive pregnancy test (typically between 5 to 12 weeks of gestation). |
| Clinical Action | Manage with prescribed anti-inflammatories, heat, or chronic care plan. | Requires immediate medical evaluation: Contact your REI, obstetrician, or proceed to the nearest emergency department. |
Clinical Roadmap: Comprehensive, Uterine-Sparing Care to Protect Your Pregnancy
Having endometriosis and adenomyosis does not mean you are destined to lose your pregnancy. By pairing disease eradication with uterine preservation, risk factors can be systematically resolved:
Unified, Uterine-Sparing Surgical Excision
Superficial ablation (burning) leaves deep disease and chronic inflammation intact. Master laparoscopic excision removes ectopic pelvic, bowel, and ovarian lesions down to clean margins.
Simultaneously, coexisting adenomyosis is addressed using uterine-sparing techniques—such as targeted in-situ Microwave Ablation (MWA), Radiofrequency Ablation (RFA), or conservative focal debulking.
This dual approach eliminates the inflammatory drivers, reduces myometrial contractility, preserves healthy uterine muscle integrity, and avoids vascular damage to ovarian reserve.
Dedicated Diagnostic Imaging & Pre-Transfer Downregulation
Prior to embryo transfer, high-definition 3D ultrasound or pelvic MRI maps the junctional zone.
If diffuse adenomyosis remains, targeted downregulation (such as prolonged GnRH-agonist or antagonist protocols) quiets local estrogen synthesis and resolves lining inflammation.
Reproductive Immunology Assessment
For patients with a history of recurrent pregnancy loss or failed euploid IVF transfers, comprehensive immune workups—evaluating NK cell toxicity, autoantibodies, thrombophilias, and cytokine ratios—allow clinicians to layer targeted immunomodulatory protocols (such as low-dose aspirin, low-molecular-weight heparin, or intralipid infusions).
Targeted Progesterone Scaffolding
Given the high prevalence of local progesterone resistance, individualized luteal phase and early gestational progesterone supplementation (frequently combining intramuscular and bioidentical vaginal formulations) provides the hormonal foundation necessary to maintain early pregnancy.
Frequently Asked Questions
Does having endometriosis mean I will definitely miscarry?
No. The majority of women with endometriosis achieve healthy, full-term pregnancies. While the relative risk of miscarriage is higher compared to individuals without the disease, it is not an absolute barrier.
Comprehensive diagnostic screening, uterine-sparing surgical clearance, and targeted medical management substantially lower these risks.
How does uterine-sparing excision help prevent pregnancy loss?
Uterine-sparing excision completely removes pelvic and retroperitoneal endometriosis lesions that flood the reproductive organs with toxic inflammatory cytokines.
By pairing this with targeted thermal modalities for adenomyosis (like MWA or RFA), surgeons treat diseased myometrium while preserving structural uterine integrity, normalizing contractility and significantly improving implantation receptivity.
If my embryos are genetically tested (euploid), can endometriosis and adenomyosis still cause a loss?
Yes. Preimplantation Genetic Testing (PGT-A) confirms that an embryo has the correct number of chromosomes, eliminating aneuploidy as the cause of loss.
However, if the uterine lining is unreceptive due to progesterone resistance, adenomyotic junctional zone disruption, or immune rejection, even a chromosomally normal embryo can fail to implant or result in an early loss.
What should I do if I experience recurrent pregnancy loss with endometriosis?
Stop running identical conception cycles.
Consult a fellowship-trained Reproductive Endocrinologist and Infertility specialist (REI) who also specializes in master endometriosis excision and reproductive immunology.
A coordinated evaluation of your pelvic anatomy, uterine wall, and immune profile is essential to uncovering and treating the root cause.
Summary Perspective
Endometriosis and coexisting adenomyosis increase miscarriage risk primarily through uterine lining receptivity defects, structural junctional zone disruption, and immune dysregulation, rather than simple egg quality deficits.
Surgical management must be unified and uterine-sparing: combining complete laparoscopic excision of pelvic disease with targeted myometrial-preserving treatments for adenomyosis.
An integrated treatment plan—pairing uterine-sparing surgical clearance with specialized reproductive immunology and hormonal protocols—gives patients with complex pelvic disease the highest probability of carrying a healthy pregnancy to term.
Endometriosis Surgical Specialists International (ESSI)
New York · New Jersey · Miami · internationalendo.com
Medical Disclaimer: This article is strictly educational and does not constitute individual medical, surgical, or fertility advice. Pregnancy management and reproductive treatments must always be individualized under the care of a licensed reproductive endocrinologist or maternal-fetal medicine specialist.
